Impairment of internally developed software with no expected future revenue
First written in FY2022. . Latest entry: FY2025.
The whole theme swung hardest in 2020: 4 of 7 companies on the "Worse" side.
0 other companies' latest entry also says "Other".
- FY2025Update on impairment loss for subsidiary-owned softwareAnnual report
「Shibuya-ku, Tokyo Operating assets Software ¥883,528 thousand」
The impairment loss of ¥883,528 thousand was recognized for software held by DeSC Healthcare, not for internally developed software. - FY2024Update on impairment loss for internally developed softwareAnnual report
「For internally developed software that is not expected to generate future revenue, the carrying amount was reduced to its recoverable amount, and the reduction of ¥6,968 thousand was recognized as an impairment loss under extraordinary losses.」
Following the impairment loss recognized for software owned by DeSC in the previous fiscal year, the company recognized an impairment loss of ¥69 million for internally developed software in the current fiscal year. - FY2023-Q3Additional impairment loss recognized for subsidiary-owned softwareAnnual report
「Under extraordinary gains and losses, the company recognized an impairment loss of ¥120 million for software owned by DeSC.」
In addition to its existing internally developed software, the company recognized an impairment loss of ¥120 million for software owned by DeSC. - FY2022First statedAnnual report
「The carrying amount of internally developed software that is not expected to generate future revenue was reduced to its recoverable amount, and the reduction of ¥46,280 thousand was recognized as an impairment loss under extraordinary losses.」
The company has for the first time presented as a separate topic the fact that an impairment loss of ¥46,280 thousand was recognized for internally developed software that was no longer expected to generate future revenue.